The @IAEAorg is supporting Asia-Pacific countries to improve cancer management through theranostics.
At a regional training in China last week, participants learned about the clinical application of therapeutic radiotracers labelled with beta and alpha-emitting radionuclides.
Common sense prevails ! Nuclear medecine therapy is done by nuclear medecine physicians.
NRC Votes on Training and Experience Requirements - SNMMI: https://t.co/SmjL1UZ0b5 @JournalofNucMed @CzerninJohannes @SNM_MI#theranostics
Gran respuesta después de solo 2 dosis de 177Lu iPSMA (200 mCi x 2) disminuyendo el 96,5 % de la carga tumoral metabólica. 🇲🇽 #INCan#nucelarmedicine#theranostics
@LGMexico tengo un CineBeam PF50KA, no prende y en ninguno de los teléfonos de su página oficial me ofrecen algún tipo de solución, donde me puede dar algún soporte técnico.
🚨El PET PSMA es un tipo de imagen molecular usada en cancer de la próstata y ha sido incluido recientemente en las guías de NCCN 2022, gracias programas como @OPUS en #INCAn sa ha logrado que más pacientes tengan el acceso este tipo de modalidades de imagen.
The #FDA has granted breakthrough therapy designation to 177Lu-PSMA-617, an investigational #radioligandtherapy for the treatment of metastatic castration-resistant #prostatecancer (mCRPC)
https://t.co/bREULjxm0a
PYLARIFY can detect the spread of disease well before standard imaging and can be a transformative diagnostic tool that helps clinicians develop treatment plans based on a much more accurate understanding of a patient’s distribution of disease. https://t.co/3xmq1bv5fO
A little space for discussing about the latest evidences in Nuclear Medicine! This video has been prepared by a young colleague Federica Stracuzzi in collaboration with the Italian Association of Nuclear Medicine! Enjoy!